Rebus Holdings, Inc. (RBSH)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Nov 3, 2026
Rebus Holdings Market Cap
Rebus Holdings has a market cap or net worth of $32 as of November 3, 2026. It is the 53,192nd most valuable company in the world and the 9,130th biggest in the United States. Its market cap has decreased by 99.00% in one year.
Market Cap
32.00
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#9,130 United States
PE Ratio
0.00
ChartMarket Cap Chart
Since November 2, 2009, Rebus Holdings's market cap has decreased from 30.37M to 32.00, a decrease of -100.00%. That is a compound annual growth rate of -55.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 3.21K | 9,940.63% |
| Dec 31, 2024 | 32.00 | -99.98% |
| Dec 29, 2023 | 162.27K | -32.67% |
| Dec 30, 2022 | 241.00K | -12.12% |
| Dec 31, 2021 | 274.23K | -69.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kaleido Biosciences | 4.26K |
| ONE Bio | 4.19K |
| MetaStat | 4.11K |
| Baseline Productions | 4.11K |
| Xeno Transplants | 4.04K |
| Synovics Pharmaceuticals | 3.65K |
| Innoveren Scientific | 3.20K |
| Hemagen Diagnostics | 3.10K |